BBIO
Bridgebio Pharma
$72.50
−$3.58 (−4.71%)Sep 10, 2026
Key metrics
The numbers that frame BBIO today
- Market cap
- $14.17B
- P/E (TTM)
- -20.5
- EV / FCF
- -36.7
- Gross margin
- 94.4%
- EV / Sales
- 22.4
- ROIC
- -31.7%
- Div yield
- 0%
- 52wk Low
- $48.78
- 52wk High
- $93.42
Growth
Revenue and earnings trend for BBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BBIO
Is Bridgebio Pharma a good buy?
Hold. Bridgebio Pharma has excellent momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Bridgebio Pharma is selling at a high price.
What is the market capitalization of BBIO?
Bridgebio Pharma's market capitalization is $14.17B.
What is the P/E ratio for BBIO stock?
Bridgebio Pharma's current P/E ratio is -20.5.
What is the 52-week high for BBIO stock?
The 52-week high for Bridgebio Pharma is $93.42. The current close of $72.50 is 22.4% below that high.
What is the 52-week low for BBIO stock?
The 52-week low for Bridgebio Pharma is $48.78. The current close of $72.50 is 48.6% above that low.
Does BBIO stock pay dividends?
Bridgebio Pharma does not currently show a dividend per share in the company data.